Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of Alzheimer's disease
Leonardo Brunetti, Rosalba Leuci, Antonio Carrieri, et al.
European Journal of Medicinal Chemistry (2022) Vol. 237, pp. 114358-114358
Closed Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

A comprehensive review of multi-target directed ligands in the treatment of Alzheimer’s disease
Chandni Pathak, Uma D. Kabra
Bioorganic Chemistry (2024) Vol. 144, pp. 107152-107152
Closed Access | Times Cited: 34
Analysis of skeletal diversity of multi-target directed ligands (MTDLs) targeting Alzheimer’s disease
Uzma Azam, Muhammad Moazzam Naseer, Christophe Rochais
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117277-117277
Open Access
Development of multi-targetable chalcone derivatives bearing N-aryl piperazine moiety for the treatment of Alzheimer's disease
Nilesh Gajanan Bajad, Ravi Bhushan Singh, Gajendra T.A., et al.
Bioorganic Chemistry (2024) Vol. 143, pp. 107082-107082
Closed Access | Times Cited: 4
Insight into antioxidant-like activity and computational exploration of identified bioactive compounds in Talinum triangulare (Jacq.) aqueous extract as potential cholinesterase inhibitors
Olakunle Bamikole Afolabi, Oluwaseun Ruth Olasehinde, Olutunmise Victoria Owolabi, et al.
BMC Complementary Medicine and Therapies (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Discovery of quinazolin-4(3H)-one derivatives as novel AChE inhibitors with anti-inflammatory activities
Ling Lv, Mireguli Maimaitiming, Yan Huang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 254, pp. 115346-115346
Closed Access | Times Cited: 11
MIL-125-NH2 loaded on MXene to promote hydrogen evolution reaction for electrocatalytic water splitting
H. Zhang, Yiping Liu, Chenxi Zhang, et al.
Journal of Electroanalytical Chemistry (2024) Vol. 962, pp. 118275-118275
Closed Access | Times Cited: 3
Novel Dual-Acting Hybrids Targeting Type-2 Cannabinoid Receptors and Cholinesterase Activity Show Neuroprotective Effects In Vitro and Amelioration of Cognitive Impairment In Vivo
Claudia Mugnaini, Antonella Brizzi, Marco Paolino, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 5, pp. 955-971
Closed Access | Times Cited: 3
Role of copper chelating agents: between old applications and new perspectives in neuroscience
Rosalba Leuci, Leonardo Brunetti, Vincenzo Tufarelli, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 3, pp. 751-762
Open Access | Times Cited: 3
Bioinspired design of highly specific fluorescent probe for butyrylcholinesterase imaging in living cells and Alzheimer's disease model
Zhen‐Qing Yu, Yongsheng Ma, Shuai Xu, et al.
Sensors and Actuators B Chemical (2024) Vol. 410, pp. 135662-135662
Closed Access | Times Cited: 2
Lead optimization based design, synthesis, and pharmacological evaluation of quinazoline derivatives as multi-targeting agents for Alzheimer's disease treatment
Akash Verma, Digambar Kumar Waiker, Neha Singh, et al.
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116450-116450
Closed Access | Times Cited: 2
Chiral pyrrolidines as multipotent agents in Alzheimer and neurodegenerative diseases
Antonio Carrieri, Alexia Barbarossa, Modesto de Candia, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 110, pp. 117829-117829
Open Access | Times Cited: 2
Novel Phenothiazine/Donepezil-like Hybrids Endowed with Antioxidant Activity for a Multi-Target Approach to the Therapy of Alzheimer’s Disease
Alessia Carocci, Alexia Barbarossa, Rosalba Leuci, et al.
Antioxidants (2022) Vol. 11, Iss. 9, pp. 1631-1631
Open Access | Times Cited: 13
Design, Synthesis, and Biological Activity of Donepezil: Aromatic Amine Hybrids as Anti-Alzheimerss Drugs
Dan Wan, Fengqin Wang, Jiang Xie, et al.
ACS Omega (2023) Vol. 8, Iss. 24, pp. 21802-21812
Open Access | Times Cited: 7
Design, synthesis, and biological evaluation of novel donepezil-tacrine hybrids as multi-functional agents with low neurotoxicity against Alzheimer’s disease
Ningwei Wang, Wenlong Jia, Junqin Wang, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 107010-107010
Closed Access | Times Cited: 6
Synthesis and biological evaluation of O4′-benzyl-hispidol derivatives and analogs as dual monoamine oxidase-B inhibitors and anti-neuroinflammatory agents
Ahmed H.E. Hassan, Yeonwoo Choi, Rium Kim, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 110, pp. 117826-117826
Closed Access | Times Cited: 1
Multi-target QSAR modeling for the identification of novel inhibitors against Alzheimer's disease
Vinay Kumar, Achintya Saha, Kunal Roy
Chemometrics and Intelligent Laboratory Systems (2022) Vol. 233, pp. 104734-104734
Closed Access | Times Cited: 7
DISCOVERY OF DONEPEZIL-LIKE COMPOUNDS AS POTENTIAL ACETYLCHOLINESTERASE INHIBITORS DETERMINED BY PHARMACOPHORE MAPPING-BASED VIRTUAL SCREENING AND MOLECULAR DOCKING
Ferah Cömert Önder
SDÜ Tıp Fakültesi Dergisi (2023) Vol. 30, Iss. 2, pp. 143-153
Open Access | Times Cited: 3
Historic recurrences in medicinal chemistry: nature-inspired structures as a new opportunity for novel multi-target anti-Alzheimer’s drugs
Luca Piemontese
Neural Regeneration Research (2023) Vol. 18, Iss. 12, pp. 2671-2672
Open Access | Times Cited: 3
In silico Strategy: A Promising Implement in the Development of Multitarget Drugs against Neurodegenerative Diseases
Purusottam Banjare, Balaji Wamanrao Matore, Anjali Murmu, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 29, pp. 2765-2791
Closed Access | Times Cited: 3
Recent Progress in the Treatment Strategies for Alzheimer’s Disease
Vinay Kumar, Kunal Roy
Neuromethods (2023), pp. 3-47
Closed Access | Times Cited: 2
Exploring the Pivotal Role of Pyrrolidine Ring in Search of Multipotent Agents in Neurodegenerative Diseases
Antonio Carrieri, Alexia Barbarossa, Modesto de Candia, et al.
(2024)
Closed Access
3-((2-(4-Chloro-5-ethoxy-2-nitrophenoxy)acetamido)methyl)phenyl-dimethylcarbamate
Rosalba Leuci, Daniela Dininno, Marco Paparella, et al.
Molbank (2024) Vol. 2024, Iss. 3, pp. M1863-M1863
Open Access
Rivastigmine structure-based hybrids as potential multi-target anti-Alzheimer’s drug candidates
Rosalba Leuci, Slobodanka Simic, Antonio Carrieri, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107895-107895
Open Access
Development of selective sigma-1 receptor ligands with antiallodynic activity: a focus on piperidine and piperazine scaffolds
Giuseppe Cosentino, Maria Dichiara, Francesca Alessandra Ambrosio, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 117037-117037
Closed Access
Approved Drug Regimens, Combinations, and Delivery Systems for Alzheimer’s Disease
Golamari Siva Reddy, Sreenu Thalla
(2024), pp. 177-198
Closed Access
Page 1 - Next Page

Scroll to top